Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001193125-26-086276 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-02 | 2026-02-26 | LMAT | Roberts David B | Pres, Dir | A - Grant | $0.00 | +1,660 | 26.6K | +7% | $0 |
| D | 2026-03-02 | 2026-02-27 | LMAT | Roberts David B | Pres, Dir | S - Sale+OE | $106.80 | -8,464 | 18.0K | -32% | -$904.0K |
| DM | 2026-03-02 | 2026-02-26 | LMAT | Roberts David B | Pres, Dir | F - Tax | $113.69 | -147 | 26.5K | -0.6% | -$16.7K |
| D | 2026-03-02 | 2026-02-26 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | +3 | 26.6K | +0.0% | $0 |
| D | 2026-03-02 | 2026-02-26 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | -3 | 9.38 | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | A | A | 1,514 | $0.00 | 26,444 | D | — | — | (F1) These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years. |
| 2 | Common | Common Stock | 2026-02-26 | A | A | 146 | $0.00 | 26,590 | D | — | — | (F2) These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on February 18, 2025. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on December 6th over the next three years (2026, 2027 and 2028). |
| 3 | Common | Common Stock | 2026-02-27 | S | D | 8,464 | $106.80 | 17,979 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.85 to $107.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-02-26 | F | D | 13 | $113.69 | 26,443 | D | — | — | (F5) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on February 18, 2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 5 | Common | Common Stock | 2026-02-26 | M | A | 3 | $0.00 | 26,593 | D | — | — | (F3) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 6 | Common | Common Stock | 2026-02-26 | F | D | 134 | $113.69 | 26,456 | D | — | — | (F4) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 7 | Derivative | Dividend Equivalent Rights | 2026-02-26 | M | D | 3 | $0.00 | 9.38 | D | — · — to — | 3 Common Stock | (F7) These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |